|Bid||1.1500 x 2041500|
|Ask||1.1550 x 261700|
|Day's range||1.1500 - 1.1750|
|52-week range||0.9700 - 1.5420|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||23 Nov 2021 - 28 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||1.74|
AUCKLAND, New Zealand, August 10, 2021--Aroa Biosurgery's Endoform™ Natural achieves significantly improved wound closure for diabetic foot ulcers compared to traditional collagen dressings
The simplest way to benefit from a rising market is to buy an index fund. When you buy individual stocks, you can make...
Investors in Aroa Biosurgery Limited ( ASX:ARX ) had a good week, as its shares rose 6.2% to close at AU$1.20 following...